These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28953617)

  • 1. Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.
    Song J; Shao Q; Li C; Liu H; Li J; Wang Y; Song W; Li L; Wang G; Shao Z; Fu R
    Medicine (Baltimore); 2017 Sep; 96(39):e7952. PubMed ID: 28953617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of miR-21 in diffuse large B cell lymphoma].
    Li CH; Fu R; Wang YH; Song WJ; Ruan EB; Qu W; Wang HQ; Wang GJ; Song J; Wang XM; Wu YH; Xing LM; Liu H; Li LJ; Guan J; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):339-43. PubMed ID: 24763002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance].
    Song GQ; Gu L; He BS; Pan YQ; Wang SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1603-9. PubMed ID: 25543482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
    Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
    Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1.
    Wang R; Shen J; Su N; Wang Q; Zhang M; Liu C
    Hum Cell; 2020 Oct; 33(4):1091-1098. PubMed ID: 32529465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.
    Wang X; Cao X; Sun R; Tang C; Tzankov A; Zhang J; Manyam GC; Xiao M; Miao Y; Jabbar K; Tan X; Pang Y; Visco C; Xie Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WWL; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Winter JN; Piris MA; Li S; Miranda RN; Medeiros LJ; Li Y; Xu-Monette ZY; Young KH
    Neoplasia; 2018 Jun; 20(6):574-593. PubMed ID: 29734016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
    Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
    Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198.
    Wang R; Shen J; Wang Q; Zhang M
    Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
    Huang Y; Lin Y; Song X; Wu D
    Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
    Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
    Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p.
    Zhao J; Su L; Jiang J
    Med Sci Monit; 2020 Sep; 26():e922810. PubMed ID: 32976381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
    Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
    Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of MiR-155 in Tissue of Patients with Diffuse Large B-Cell Lymphoma and Its Effect on Cell Biological Characteristics].
    Han B; Gao ZD; Wang HX; Wang ZH; Fan CB; Liu JL; Tian M; Zhao HG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):445-451. PubMed ID: 30998152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
    Cao QW; Li HY; Yao XX; Wang JF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma.
    Pfeifer M; Grau M; Lenze D; Wenzel SS; Wolf A; Wollert-Wulf B; Dietze K; Nogai H; Storek B; Madle H; Dörken B; Janz M; Dirnhofer S; Lenz P; Hummel M; Tzankov A; Lenz G
    Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12420-5. PubMed ID: 23840064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function].
    Qiu C; Zhang QH; Wang GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1415-1422. PubMed ID: 36208243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.